At the 2018 PDA/FDA Joint Regulatory Conference, Sept. 24-26 in Washington, DC, industry experts and U.S. FDA regulators will explore the circumstances that impact the quality, safety, and availability of drugs. Gain new perspectives and best practices on the evolving regulatory landscape, supply chain risks, quality culture, and challenges in manufacturing.
Register by Jul. 16 and save up to 400!

IVT's Stability Testing Europe allows attendees to review core FDA and ICH guidance to breaking down the latest regulatory policies, including a brand new updated WHO draft guidance for API and finished drug stability testing. Don't miss the chance to participate in hands-on training for small molecules, biologics and medical devices to harmonize global systems and enhance stability programmes.
Learn more

As the landscape continues to face an influx of regulations surrounding the reliability, consistency and accuracy of analytical methods and data, it is critical for the biopharmaceutical industry to adhere to new regulatory expectations.
Analytical Procedures & Methods Validation Europe provides a comprehensive understanding of regulatory trends and requirements, "hands-on" training for executing procedures that survive the lifecycle and solutions to challenges within the laboratory.
Learn more